Possible involvement of TNF-α in left ventricular remodeling in hemodialysis patients

Journal of Nephrology

Volumn 16, Issue 5, 2003, Pages 641-649

  Nishimura, Masato ^a   Hashimoto, Tetsuya ^a   Kobayashi, Hiroyuki ^a   Fukukda, Toyofumi ^a   Okino, Koji ^a   Yamamoto, Noriyuki ^a   Nakamura, Naoto ^b   Yoshikawa, Toshikazu ^b   Takahashi, Hakuo ^c   Ono, Toshihiko ^a  

^a Toujinkai Hospital   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

BNP; Congestive heart failure; Diabetes mellitus; Hemodialysis; Left ventricular remodeling; TNF

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE SIZE; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; BLOOD; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY;

DIABETIC NEPHROPATHIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RENAL DIALYSIS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 1442331928     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. London GM. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 2002; 17(suppl 1): S29-36.
2. Dzau VJ. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes. Curr Opin Nephrol Hypertens 1993; 2: 27-32.
3. Calderone A, Takahashi N, Izzo NJ Jr, Thaik CM, Colucci WS. Pressure- and volume-incluced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factors mRNAs. Circulation 1995; 92: 2385-90.
4. Grossmann W. Cardiac hypertrophy: useful adaptation or pathological process? Am J Med 1980; 69: 576-84.
5. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994; 45: 491-503.
6. Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL. Pathophysiologically, relevant concentration of tumor necrosis factor-α promotes progressive left ventricular dysfunction and remodeling in rats. Circulation 1998; 97: 1382-91.
7. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-41.
8. Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK. Tumor necrosis factor-α in severe congestive heart failure. Br Heart J 1993; 70: 141-3.
9. Katz SD, Rao R, Berman JW, Schwarz M, Demopoulos L, Bijou R, Lejemtel TH. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Circulation 1994; 90: 12-6.
10. Torre-Amione G, Kapadia S, Benedict C, Oral Y, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 28: 964-71.
11. Milani RV, Mehra MR, Endres S, Eigler A, Cooper ES, Lavie CJ Jr, Ventura HO. The clinical relevance of circulating tumor necrosis factor-α in acute decompensated chronic heart failure without cachexia. Chest 1996; 110: 992-5.
12. Nozaki N, Yamaguchi S, Shirakabe M, Makamura H, Tomoike H. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Jpn Circ J 1997; 61: 657-64.
13. Yamaoka M, Yamaguchi S, Okuyama M, Tomoike H. Anti-inflammatory cytokine profile in human heart failure - Behavior of interleukin-10 in association with tumor necrosis factor-alpha. Jpn Cir J 1999; 63: 951-6.
14. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman M, Mann DL. Tumor necrosis factor-α provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 1997; 95: 1247-52.
15. Shaldon S, Deschodt G, Branger B, Granolleras C, Baldamus CA, Koch KM, Lysaght MJ, Dinarello CA. Haemodialysis hypotension: the interleukin hypothesis restated. Proc Eur Dial Transplant Assoc 1985; 22: 229-43.
16. Nishimura M, Hashimoto T, Kobayashi H, Fukuda T, Okino K, Yamamoto N, Nakamura N, Yoshikawa T, Takahashi H, Ono T. Different remodeling against left ventricular overload between diabetic and non-diabetic hemodialysis patients. Clin Exp Pharmacol Physiol 2003; 30: 786-92.
17. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884-90.
18. Stack AG, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis 2001; 38: 992-1000.
19. Sahn DJ, DeMaria A, Kisso J, Weyman A. The Committee on M-Mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
20. Devereux RB, Koren MJ, deSimone G, Okin PM, Kligfield P. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J 1993; 14 (suppl D): S8-15.
21. Gurantz D, Cowling RT, Villarreal FJ, Greenberg BH. Tumor necrosis factor-α upregulates angiotensin II type 1 receptors on cardiac fibroblasts. Circ Res 1999; 85: 272-9.
22. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 1993; 72: 1245-54.
23. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993; 88: 2849-61.
24. Crawford DC, Chobanian AV, Brecher P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res 1994; 74: 727-39.
25. Kim NN, Villarreal FJ, Printz MP, Lee AA, Dillmann WH. Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts. Am J Physiol 1995; 269: E426-37.
26. Thaik CM, Calderone A, Takahashi N, Colucci WS. Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest 1995; 96: 1093-9.
27. Hirota H, Yoshida K, Kishimoto T, Taga T. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 1995; 92: 4862-66.
28. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988-4.
29. Nitta K, Kawashima A, Yumura W, Naruse M, Oba T, Kabaya T, Nihei H. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis. Am J Nephrol 1998; 18: 411-5.
30. Mallamaci F, Zoccali C, Tripepi G, Benedetto FA, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Stancanelli B, Malatino LS, Creed Investigators. The Cardiovascular Risk Extended Evaluation. Diagnostic potential of cardiac natriuretic peptide in dialysis patients. Kidney Int 2001; 59: 1559-66.
31. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effect of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993; 92: 2303-12.
32. Dinarello CA. Amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (cachectin). J Immunol 1986; 2: 68-89.
33. Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990; 37: 85-93.
34. Laude-Sharp M, Caroff M, Simard L, Pusineri C, Kazatchkine MD, Haeffner-Cavaillon N. Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS). Kidney Int 1990; 38: 1089-94.
35. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α. Kidney Int 1990; 37: 116-25.
36. Vonhof S, Brost B, Stille-Siegener M, Grumbach IM, Kreuzer H, Figulla HR. Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy. Int J Cardiol 1998; 63: 237-44.
37. Aukrust P, Ueland T, Lien E, Bendtzen K, Muller F, Andreassen AK, Nordoy I, Aass H, Espevik T, Simonsen S, Froland SS, Gullestad L. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1999; 83: 376-82.
38. Zhao S-P, Ku T-D. Elevated tumor necrosis factor alpha of blood mononuclear cells in patients with congestive heart failure. Int J Cardiol 1999; 71: 259-63.
39. Giroir BP, Johnson JH, Brown T, Allen GL, Beutler B. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 1992; 90: 693-8.
40. Giroir BP, Horton JW, White JD, McIntyre KL, Lin CQ. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol 1994; 267: H118-24.
41. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, Giroir B. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-a. Circulation 1998; 97: 1375-81.
42. Kapadia S, Oral H, Lee J, Nakano M, Taffet GE, Mann L. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res 1997; 81: 187-95.
43. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992; 13: 151-3.
44. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994; 76: 959-62.
45. Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 1989; 264: 11974-80.
46. De Groote D, Grau GE, Dehart I, Franchimont P. Stabilization of functional tumor necrosis factor-α by its soluble TNF receptors. Eur Cytokine Netw 1993; 4: 359-62.
47. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O. Tumor necrosis factor receptors in patients with various degrees of congestive heart failure. Circulation 1995; 92: 1479-86.